Phase II trial of neoadjuvant osimertinib for surgically resectable EGFR-mutated non-small cell lung cancer
Jacqueline V. Aredo,Anatoly Urisman,Matthew A. Gubens,Claire Mulvey,Greg M. Allen,Julia K. Rotow,Daniel Lucas Kerr, Turja Chakrabarti, Bianca Bacaltos, Megan Gee,Kirk Jones,Dara L. Aisner,Tejas Patil,Erin Lynn Schenk,Trever G. Bivona,Jonathan W. Riess,Melissa Coleman,Johannes Ruediger Kratz,David Jablons,Collin M. Blakely JOURNAL OF CLINICAL ONCOLOGY(2023)
AI 理解论文
溯源树
样例